Sleep as a new target for improving outcomes in idiopathic pulmonary fibrosis

C Mermigkis, I Bouloukaki, SE Schiza - Chest, 2017 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is the most common type of interstitial pneumonia but
remains a disease with a poor outcome. Two drugs, pirfenidone and nintedanib, have shown …

[HTML][HTML] Obstructive sleep apnea syndrome and cardiovascular disease: The influence of C-reactive protein

I Bouloukaki, C Mermigkis, EM Kallergis… - World journal of …, 2015 - ncbi.nlm.nih.gov
Obstructive sleep apnea syndrome (OSAS) is a common medical condition, associated with
atherosclerosis and cardiovascular disease (CVD). The underlying pathophysiologic …

Obstructive sleep apnea should be treated in patients with idiopathic pulmonary fibrosis

C Mermigkis, I Bouloukaki, K Antoniou… - Sleep and …, 2015 - Springer
Study objectives The most recent idiopathic pulmonary fibrosis (IPF) guidelines include
obstructive sleep apnea (OSA) among the IPF-associated comorbidities. Furthermore, they …

Intensive versus standard follow-up to improve continuous positive airway pressure compliance

I Bouloukaki, K Giannadaki, C Mermigkis… - European …, 2014 - Eur Respiratory Soc
We aimed to compare the effect of intensive versus standard interventions on continuous
positive airway pressure (CPAP) adherence 2 years after CPAP initiation, as well as on …

Idiopathic pulmonary fibrosis and sleep disorders: no longer strangers in the night

…, O Torre, D Visca, I Bouloukaki… - European …, 2015 - Eur Respiratory Soc
The prevalence of obstructive sleep apnoea (OSA) is continuously increasing in patients
with idiopathic pulmonary fibrosis (IPF) and, for the first time, the recent IPF guidelines …

European Respiratory Society statement on sleep apnoea, sleepiness and driving risk

…, R Riha, F Barbe, I Bouloukaki… - European respiratory …, 2021 - Eur Respiratory Soc
Obstructive sleep apnoea (OSA) is highly prevalent and is a recognised risk factor for motor
vehicle accidents (MVA). Effective treatment with continuous positive airway pressure has …

[HTML][HTML] Evaluation of inflammatory markers in a large sample of obstructive sleep apnea patients without comorbidities

I Bouloukaki, C Mermigkis, N Tzanakis… - Mediators of …, 2017 - hindawi.com
Systemic inflammation is important in obstructive sleep apnea (OSA) pathophysiology and
its comorbidity. We aimed to assess the levels of inflammatory biomarkers in a large sample …

[HTML][HTML] Translation and validation of Berlin questionnaire in primary health care in Greece

I Bouloukaki, ID Komninos, C Mermigkis… - BMC pulmonary …, 2013 - Springer
Background The aim of our study was to validate a Greek translation of the Berlin
Questionnaire (BQ) for obstructive sleep apnoea syndrome (OSAS) and to explore whether this …

[HTML][HTML] Excessive daytime sleepiness in obstructive sleep apnea patients treated with continuous positive airway pressure: data from the European Sleep Apnea …

…, OK Basoglu, G Trakada, I Bouloukaki… - Frontiers in …, 2021 - frontiersin.org
Excessive daytime sleepiness (EDS) is a symptom of obstructive sleep apnea (OSA) that
resolves under treatment with continuous positive airway pressure (CPAP). In some patients, …

Sleep patterns in patients with acute coronary syndromes

SE Schiza, E Simantirakis, I Bouloukaki, C Mermigkis… - Sleep Medicine, 2010 - Elsevier
BACKGROUND: Little is known about sleep quality in patients with acute coronary syndromes
(ACS) admitted to the coronary care unit (CCU). The aim of this study was to assess …